Aethlon Medical is a clinical-stage company focused on the development of innovative therapeutic solutions aimed at addressing unmet medical needs, particularly in the areas of infectious diseases and cancer. The company is primarily known for its work on the Aethlon Hemopurifier, a device designed to selectively remove pathogens and other harmful substances from the blood. Aethlon Medical is dedicated to advancing its technologies through rigorous clinical studies, with the goal of improving patient outcomes and enhancing the effectiveness of current treatment options. Read More
BALA CYNWYD, Pa., Sept. 17, 2026 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.
Halper Sadeh LLC, an investor rights law firm, is investigating the merger of Aethlon Medical, Inc. (NASDAQ: AEMD) and North Immunology, Inc. Upon closing of the proposed transaction, Aethlon shareholders are expected to own approximately 4.75% of the combined company.
Gainers Quoin Pharmaceuticals (NASDAQ:QNRX) shares rose 24.6% to $6.42 during Friday's regular session. The company's market cap stands at $10.3 million. Aethlon Medical (NASDAQ:AEMD) shares moved upwards by
Gainers Quoin Pharmaceuticals (NASDAQ:QNRX) shares rose 41.4% to $7.29 during Friday's pre-market session. The company's market cap stands at $10.3 million. Aethlon Medical (NASDAQ:AEMD) stock moved upwards by
Gainers Aethlon Medical (NASDAQ:AEMD) stock rose 50.7% to $3.27 during Thursday's after-market session. The market value of their outstanding shares is at $1.6 million. Modular Medical (NASDAQ:MODD) stock rose
NEW YORK, March 13, 2026 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced that presentations from the Life Sciences Virtual Investor Forum, held March 11th – 12th, are now available for on-demand viewing.
The Company invites individual and institutional investors, as well as advisors and analysts with an interest in the life sciences sector, to attend live, interactive presentations at VirtualInvestorConferences.com
